Head-To-Head Contrast: Henkel AG & Co. KGaA (OTCMKTS:HENKY) and Nihon Kohden (OTCMKTS:NHNKY)

Henkel AG & Co. KGaA (OTCMKTS:HENKY) and Nihon Kohden (OTCMKTS:NHNKY) are both consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Profitability

This table compares Henkel AG & Co. KGaA and Nihon Kohden’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Henkel AG & Co. KGaA	N/A	N/A	N/A
Nihon Kohden	7.66%	15.08%	11.90%

Institutional and Insider Ownership

0.0% of Henkel AG & Co. KGaA shares are owned by institutional investors. Comparatively, 0.1% of Nihon Kohden shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Henkel AG & Co. KGaA and Nihon Kohden’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henkel AG & Co. KGaA	$23.28 billion	1.48	$1.43 billion	N/A	N/A
Nihon Kohden	$1.54 billion	N/A	$117.94 million	$0.69	20.52

Henkel AG & Co. KGaA has higher revenue and earnings than Nihon Kohden.

Volatility and Risk

Henkel AG & Co. KGaA has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500. Comparatively, Nihon Kohden has a beta of -0.06, indicating that its share price is 106% less volatile than the S&P 500.

Dividends

Henkel AG & Co. KGaA pays an annual dividend of $0.33 per share and has a dividend yield of 1.7%. Nihon Kohden pays an annual dividend of $0.13 per share and has a dividend yield of 0.9%. Nihon Kohden pays out 18.8% of its earnings in the form of a dividend.

Analyst Ratings

This is a summary of current ratings and recommmendations for Henkel AG & Co. KGaA and Nihon Kohden, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henkel AG & Co. KGaA	1	2	0	0	1.67
Nihon Kohden	0	0	0	0	N/A

Summary

Henkel AG & Co. KGaA beats Nihon Kohden on 5 of the 9 factors compared between the two stocks.

About Henkel AG & Co. KGaA

Henkel AG & Co. KGaA, together with its subsidiaries, engages in the adhesive technologies and beauty care, and laundry and home care businesses worldwide. It operates in two segments, Adhesive Technologies and Consumer Brands segments. The company offers adhesives, sealants, and functional coatings for various business areas, including packaging and consumer goods; mobility and electronics; and craftsmen, construction, and professional industries. It also provides hair styling, hair coloring, and hair care products; and body products, as well as distributes its products through brick-and-mortar stores, hair salons, and digital channels. In addition, the company offers heavy-duty and specialty detergents, fabric softeners, laundry performance enhancers, and other fabric care products; hand and automatic dishwashing products; cleaners for bathroom and toilet applications; household, glass, and specialty cleaners; and insect control products. The company was founded in 1876 and is headquartered in Düsseldorf, Germany.

About Nihon Kohden

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.